GlassScriptPhysician profile
Umar R Karaman
NPI 1346684214
$19,016.13
in general payments reported to CMS, 2019-2025
42 companies · $2,889 in 2025
The $2,889 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $3,696 · 2021: $3,658 · 2022: $1,590 · 2023: $4,264 · 2024: $1,850 · 2025: $2,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,812 · Travel and Lodging: $3,553 · Education: $344 · Honoraria: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,811.80 |
| Travel and Lodging | $3,552.72 |
| Education | $344.04 |
| Honoraria | $295.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,587.21 | 2021-2025 | Altaviva, Interstim |
| Axonics, INC. | $3,315.36 | 2021-2024 | Axonics, Bulkamid |
| Medtronic USA, INC. | $3,036.31 | 2019-2020 | |
| Astellas Pharma US INC | $1,536.05 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Boston Scientific Corporation | $988.55 | 2019-2025 | Ams 700, Axonics, Solyx Sis System |
| Procept Biorobotics Corporation | $730.17 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $510.33 | 2019-2025 | |
| Pfizer INC. | $390.15 | 2019-2025 | |
| Caldera Medical, INC | $389.96 | 2022-2023 | Desara |
| Ferring Pharmaceuticals INC. | $323.19 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $291.94 | 2021-2025 | Jelmyto |
| Coloplast Corp | $263.50 | 2019-2024 | Speedicath |
| Endo Pharmaceuticals INC. | $246.82 | 2019-2023 | Edex, Xiaflex, Aveed |
| Amgen INC. | $233.97 | 2019-2024 | Prolia |
| Janssen Biotech, INC. | $231.06 | 2019-2025 | Erleada, Akeega |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Karaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.